-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In people with a history of SARS-CoV-2 infection, a single dose of mRNA vaccine has been reported to induce an immune response similar to that in people who received two doses of the vaccine and had no history of such infection
In people with a history of SARS-CoV-2 infection, a single dose of mRNA vaccine has been reported to induce an immune response similar to that in people who received two doses of the vaccine and had no history of such infection
Researchers identified 30 patients registered at the Arthritis and Rheumatology Centre of Excellence in Cochin, India, who were infected with SARS-CoV-2 between August 2020 and July 2021 and received a serial dose of ChAdOx1 vaccine (infection plus vaccine).
Researchers identified 30 patients registered at the Arthritis and Rheumatology Centre of Excellence in Cochin, India, who were infected with SARS-CoV-2 between August 2020 and July 2021 and received a serial dose of ChAdOx1 vaccine (infection plus vaccine).
Among the 120 patients in the four groups , the mean age was 55.
Source: Shenoy, Padmanabha et al.
Hybrid immunity versus vaccine-induced immunity against SARS-CoV-2 in patients with autoimmune rheumatic diseases.
The Lancet Rheumatology, Volume 4, Issue 2, e80 - e82
Leave a comment here
